Soligenix (SNGX) Current Leases (2021 - 2026)
Soligenix's (SNGX) quarterly Current Leases came in at $117235.0 in Q1 2026, up 48.16% YoY from $79125.0 in Q1 2025, and up 2.82% on a QoQ basis from $114023.0 in Q4 2025.
Soligenix (SNGX) Current Leases (2021 - 2026) Analysis & Trends
Soligenix (SNGX) has 6 years of Current Leases data on file, last reported at $117235.0 in Q1 2026.
- Quarterly Current Leases rose 48.16% year-over-year to $117235.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $117235.0 (up 48.16% YoY) and the FY2025 annual result came in at $114023.0, up 1.93% from the prior year.
- Current Leases grew to $117235.0 in Q1 2026, from $114023.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $132114.0 in Q3 2024 to a low of $75230.0 in Q1 2022.
- A 5-year average of $111166.5 and a median of $112051.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases soared 48.94% — and 2025, when it tumbled 36.77%.
- Tracing SNGX's Current Leases over 5 years: stood at $108948.0 in 2022, then rose by 11.76% to $121765.0 in 2023, then fell by 8.13% to $111862.0 in 2024, then climbed by 1.93% to $114023.0 in 2025, then rose by 2.82% to $117235.0 in 2026.
- The last three Current Leases figures came in at $117235.0 (Q1 2026), $114023.0 (Q4 2025), and $111134.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Soligenix | 6.26 Mn | 6.26 Mn | - | 120,515.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,515.00 |
| Mar 31, 2026 | 117,235.00 |
| Dec 31, 2025 | 114,023.00 |
| Sep 30, 2025 | 111,134.00 |
| Jun 30, 2025 | 108,814.00 |
| Mar 31, 2025 | 79,125.00 |
| Dec 31, 2024 | 111,862.00 |
| Sep 30, 2024 | 132,114.00 |
| Jun 30, 2024 | 128,592.00 |
| Mar 31, 2024 | 125,143.00 |
| Dec 31, 2023 | 121,765.00 |
| Sep 30, 2023 | 118,459.00 |
| Jun 30, 2023 | 115,221.00 |
| Mar 31, 2023 | 112,051.00 |
| Dec 31, 2022 | 108,948.00 |
| Sep 30, 2022 | 106,165.00 |
| Jun 30, 2022 | 103,949.00 |
| Mar 31, 2022 | 75,230.00 |
| Dec 31, 2021 | 106,151.00 |